According to a statement, the coronavirus vaccine developed by the drug company AstraZeneca and Oxford University showed 70% effectiveness in a trial involving 23,000 individuals. In addition, the effectiveness recorded is between 62% to 90% depending on the dose of vaccine,
Based on a statement submitted by AstraZeneca CEO Pascal Soriot, his company vaccine will remain effective and will have an immediate impact.
Although the drug showed 90% effectiveness when given half a dose followed by a full dose in at least a month, the result was 62% when given 2 full doses in the same period. Therefore, the combined analysis has resulted in 70% effectiveness.
In addition, the vaccine is rumored to be stored, transported and operated in cold conditions between 2 to 8 degrees Celsius for at least 6 months.
In addition, there are more than 23,000 adults currently evaluated in the trial and that number is expected to increase to 60,000 individuals. Preliminary results showed that there were 131 cases of Covid-19 infection recorded by the participants but, no serious cases.
In addition, tests will also be conducted in the United States, Japan, Russia, South Africa, Kenya and Latin America, and will also be conducted in other European and Asian countries.
Based on a statement issued by Oxford Professor Andrew Pollard, recent findings show that the drug is an effective vaccine that can save many lives.
